temokem

Introduction to temokem

Temokem is a medication available in tablet form, primarily used for treating certain aggressive brain tumors. Temokem is specifically indicated for conditions like glioblastoma multiforme and anaplastic astrocytoma, which are types of cancer affecting the brain.

Composition of temokem

Temokem contains the active ingredient Temozolomide, which is an alkylating agent. This compound works by adding an alkyl group to the DNA of cancer cells, causing damage that prevents the cells from growing and dividing.

Uses of temokem

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of temokem

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: lowered blood cell counts, increased risk of infection

Precautions of temokem

Patients taking Temokem should be aware that it can lower blood cell counts, increasing the risk of infections. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Additionally, patients with severe bone marrow suppression should avoid using this medication.

How to Take temokem

Temokem is taken orally, usually as a tablet. The typical starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of temokem

In conclusion, temokem, containing the active ingredient Temozolomide, is a part of the alkylating agents therapeutic class. It is primarily used for treating aggressive brain tumors like glioblastoma multiforme and anaplastic astrocytoma. Patients should be aware of its potential side effects and precautions, especially regarding blood cell counts and pregnancy. Always consult with a healthcare professional for proper guidance on using temokem.